8 results on '"C. Gonzalez-Fernandez"'
Search Results
2. Poster Session 5: Saturday 10 December 2011, 08:30-12:30 * Location: Poster Area
- Author
-
L. Gong, Z. Ye, Z. Zeng, M. Xia, Y. Zhong, Y. Yao, E. Lee, A. Ionescu, G. Dwivedi, G. Mahadevan, D. Jiminez, M. Frenneaux, R. Steeds, C. Moore, Z. Samad, K. Jackson, J. Castellucci, J. Kisslo, O. Von Ramm, F. D'ascenzi, V. Zaca', M. Cameli, M. Lisi, B. Natali, A. Malandrino, S. Mondillo, P. Barbier, U. Guerrini, M. Franzosi, L. Castiglioni, E. Nobili, F. Colazzo, T. Li Causi, L. Sironi, E. Tremoli, H. Clausen, S. Macdonald, C. Basaggianis, J. Newton, E. Bennati, R. Reccia, E. Bigio, M. Maccherini, M. Chiavarelli, M. Henein, M. Floria, J. Jamart, C. Arsenescu Georgescu, F. Mantovani, A. Barbieri, F. Bursi, C. Valenti, M. Quaglia, M. Modena, S. Kutty, P. Gribben, A. Padiyath, A. Polak, C. Scott, M. Waiss, D. Danford, O. Bech-Hanssen, N. Selimovic, B. Rundqvist, L. Schmiedel, C. Hohmann, S. Katzke, K. Haacke, T. Rauwolf, R. Strasser, L. R. Tumasyan, K. Adamyan, W. Kosmala, R. Derzhko, M. Przewlocka-Kosmala, A. Mysiak, B. Stachowska, D. Jedrzejuk, G. Bednarek-Tupikowska, L. Chrzanowski, J. Kasprzak, C. Wojciechowska, K. Wita, B. Busz-Papiez, Z. Gasior, K. Mizia-Stec, T. Kukulski, P. Gosciniak, W. Sinkiewicz, H. Moelmen, A. Stoylen, A. Thorstensen, H. Torp, H. Dalen, A. Groves, G. Nicholson, L. Lopez, C.-W. Goh, H. Ahn, Y. Byun, J. Kim, J. Park, J. Lee, B. Kim, K. Rhee, K. Kim, H. Yoon, Y. Hong, H. Park, Y. Ahn, M. Jeong, J. Cho, J. Kang, J. Grapsa, D. Dawson, K. Karfopoulos, G. Jakaj, P. Punjabi, P. Nihoyannopoulos, C. Ruisanchez Villar, P. Lerena Saenz, F. Gonzalez Vilchez, C. Gonzalez Fernandez, F. Zurbano Goni, J. Cifrian Martinez, R. Mons Lera, J. Ruano Calvo, R. Martin Duran, J. Vazquez De Prada Tiffe, R. Pietrzak, B. Werner, D. Voillot, O. Huttin, P. Zinzius, J. Schwartz, J. Sellal, S. Lemoine, C. Christophe, B. Popovic, Y. Juilliere, C. Selton-Suty, K. Ishii, A. Furukawa, T. Nagai, K. Kataoka, Y. Seino, K. Shimada, J. Yoshikawa, A. Tekkesin, O. Yildirimturk, Y. Tayyareci, S. Yurdakul, S. Aytekin, J. Jaroch, K. Loboz-Grudzien, Z. Bociaga, A. Kowalska, E. Kruszynska, M. Wilczynska, K. Dudek, R. Kakihara, C. Naruse, H. Hironaka, T. Tsuzuku, U. Cucchini, D. Muraru, L. Badano, E. Solda', M. Tuveri, O. Al Nono, C. Sarais, S. Iliceto, L. Santos, N. Cortez-Dias, S. Ribeiro, S. Goncalves, C. Jorge, P. Carrilho-Ferreira, D. Silva, J. Silva-Marques, M. Lopes, A. Diogo, K. Hristova, D. Vassilev, P. Pavlov, T. Katova, I. Simova, V. Kostova, R. Esposito, A. Santoro, V. Schiano Lomoriello, R. Raia, D. De Palma, E. Dores, G. De Simone, M. Galderisi, B. Zaborska, E. Makowska, E. Pilichowska, P. Maciejewski, B. Bednarz, W. Wasek, S. Stec, A. Budaj, L. Spinelli, C. Morisco, E. Assante Di Panzillo, S. Crispo, S. Di Marino, B. Trimarco, F. Farina, P. Innelli, A. Rapacciuolo, B. Polgar, F. Banyai, L. Rokusz, I. Tomcsanyi, M. Vaszily, E. Nieszner, T. Borsanyi, G. Kerecsen, I. Preda, R. G. Kiss, S. Bull, J. Suttie, D. Augustine, J. Francis, T. Karamitsos, H. Becher, B. Prendergast, S. Neubauer, S. Myerson, F. Lodge, C. Broyd, P. Milton, G. Mikhail, J. Mayet, J. Davies, D. Francis, M.-A. Clavel, P.-V. Ennezat, S. Marechaux, J. Dumesnil, A. Bellouin, S. Bergeron, P. Meimoun, T. Le Tourneau, A. Pasquet, P. Pibarot, S. Herrmann, S. Stoerk, M. Niemann, K. Hu, W. Voelker, G. Ertl, F. Weidemann, V. Aytekin, P. Kogoj, J. Ambrozic, M. Bunc, G. Di Salvo, A. Rea, B. Castaldi, S. Gala, A. D'aiello, A. Mormile, F. Pisacane, G. Pacileo, M. Russo, R. Calabro, L. Nguyen, S.-E. Ricksten, A. Jeppsson, H. Schersten, K. Boerlage-Van Dijk, Z. Yong, B. Bouma, K. Koch, M. Vis, J. Piek, J. Baan, S. Scandura, G. Ussia, A. Caggegi, V. Cammalleri, K. Sarkar, S. Mangiafico, M. Chiaranda', S. Imme', A. Pistritto, C. Tamburino, L. Ring, S. Nair, F. Wells, L. Shapiro, R. Rusk, B. Rana, G. Madrid Marcano, J. Solis Martin, A. Gonzalez Mansilla, L. Bravo, C. Menarguez Palanca, P. Munoz, E. Bouza, R. Yotti, J. Bermejo Thomas, F. Fernandez Aviles, T. Tamayo, M. Denes, O. Balint, A. Csepregi, A. Csillik, T. Erdei, A. Temesvari, J. Fernandez-Pastor, A. Linde-Estrella, F. Cabrera-Bueno, J. Pena-Hernandez, A. Barrera-Cordero, F. Alzueta-Rodriguez, E. De Teresa-Galvan, M. Merlo, M. Pinamonti, G. Finocchiaro, S. Pyxaras, G. Barbati, A. Buiatti, A. Dilenarda, G. Sinagra, R. Kuperstein, D. Freimark, S. Hirsch, M. Feinberg, M. Arad, C. Mitroi, I. Garcia Lunar, V. Monivas Palomero, S. Mingo Santos, P. Beltran Correas, E. Gonzalez Lopez, P. Garcia Pavia, J. Gonzalez Mirelis, M. Cavero Gibanel, L. Alonso Pulpon, B. Pinamonti, A. Zaidi, S. Ghani, N. Sheikh, S. Gati, R. Howes, R. Sharma, S. Sharma, M. Calcagnino, C. O'mahony, C. Coats, M. Cardona, A. Garcia, E. Murphy, R. Lachmann, A. Mehta, D. Hughes, P. Elliott, G. Di Bella, A. Madaffari, R. Donato, A. Mazzeo, M. Casale, C. Zito, G. Vita, S. Carerj, D. Marek, J. Indrakova, Z. Rusinakova, T. Skala, E. Kocianova, M. Taborsky, F. Musca, B. De Chiara, O. Belli, S. Cataldo, C. Brunati, G. Colussi, G. Quattrocchi, G. Santambrogio, F. Spano, A. Moreo, L. Rustad, K. Nytroen, L. Gullestad, B. Amundsen, S. Aakhus, N. Maroz-Vadalazhskaya, V. Shumavetc, S. Kurganovich, Y. Seljun, A. Ostrovskiy, Y. Ostrovskiy, P. Segers, A. Orda, B. Karolko, M. M. P. Driessen, J. B. Eising, C. Uiterwaal, C. K. Van Der Ent, F. J. Meijboom, Q. Shang, L. Tam, J. Sun, J. Sanderson, Q. Zhang, E. Li, C. Yu, E. Arroyo Ucar, A. De La Rosa Hernandez, C. Hernandez Garcia, P. Jorge Perez, J. Lacalzada Almeida, J. Jimenez Rivera, A. Duque Garcia, A. Barragan Acea, I. Laynez Cerdena, M. Kaldararova, I. Simkova, J. Pacak, P. Tittel, J. Masura, M. Tadic, B. Ivanovic, M. Zlatanovic, N. Damjanov, S. Maggiolini, G. Gentile, A. Bozzano, S. Suraci, E. Meles, C. Carbone, A. Tempesta, C. Malafronte, L. Piatti, F. Achilli, P. Luijendijk, A. Stevens, H. De Bruin-Bon, J. Vriend, R. Van Den Brink, H. Vliegen, B. Mulder, V. Chow, A. Ng, T. Chung, L. Kritharides, M. Iancu, M. Serban, I. Craciunescu, A. Hodo, I. Ghiorghiu, B. Popescu, C. Ginghina, G. Styczynski, C. A. Szmigielski, A. Kaczynska, J. Leszczynski, G. Rosinski, A. Kuch-Wocial, M. Slavich, M. Ancona, A. Fisicaro, M. Oppizzi, E. Marone, L. Bertoglio, G. Melissano, A. Margonato, R. Chiesa, E. Agricola, M. Mohammed, M. Cusma-Piccione, S. Piluso, S. Arcidiaco, R. Nava, R. Giuffre, L. Ciraci, M. Ferro, V. Uusitalo, M. Luotolahti, M. Pietila, M. Wendelin-Saarenhovi, J. Hartiala, M. Saraste, J. Knuuti, A. Saraste, J. Kochanowski, P. Scislo, R. Piatkowski, M. Grabowski, M. Marchel, M. Roik, D. Kosior, G. Opolski, P. E. Bartko, S. Graf, A. Khorsand, R. Rosenhek, I. Burwash, R. Beanlands, H. Baumgartner, G. Mundigler, S. Kudrnova, A. Apor, H. Huttl, F. Mori, G. Santoro, A. Oddo, G. Rosso, F. Meucci, F. Pieri, G. Squillantini, G. Gensini, M. Postula, D.-G. Park, J.-Y. Hong, S.-E. Kim, J.-H. Lee, K.-R. Han, D.-J. Oh, L. Dal Bianco, M. Beraldo, D. Peluso, A. Al Mamary, C. Aggeli, I. Felekos, E. Poulidakis, P. Pietri, G. Roussakis, G. Siasos, C. Stefanadis, H. Hoshiba, C. Miyasaka, H. Sato, A. Yamanaka, A. Lilli, M. Baratto, M. Magnacca, A. Comella, R. Poddighe, E. Talini, M. Canale, M. Chioccioli, J. Del Meglio, G. Casolo, V. A. Kuznetsov, N. N. Melnikov, D. V. Krinochkin, A. Calin, R. Enache, C. Beladan, M. Rosca, L. Lupascu, F. Purcarea, C. Calin, M. Gurzun, R. Dulgheru, A. Ciobanu, S. Magda, S. Mihaila, R. Rimbas, A. Margulescu, M. Cinteza, D. Vinereanu, A. N. Sumin, O. Arhipov, J. Yoon, J. Moon, S. Rim, E. Nyktari, A. Patrianakos, G. Solidakis, E. Psathakis, F. Parthenakis, P. Vardas, M. Kordybach, M. Kowalski, E. Kowalik, P. Hoffman, K. V. Nagy, V. Kutyifa, E. Edes, B. Merkely, A. Gerlach, C. Rost, M. Schmid, M. Rost, F. Flachskampf, W. Daniel, O. Breithardt, E. Altekin, S. Karakas, A. Yanikoglu, A. Er, A. Baktir, I. Demir, N. Deger, L. Klitsie, M. Hazekamp, A. Roest, A. Van Der Hulst, B. Gesink- Van Der Veer, I. Kuipers, N. Blom, A. Ten Harkel, K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, E. Avramidou, D. Vasilopoulou, V. Voudris, T. Florianczyk, M. Kalinowski, M. Szulik, W. Streb, B. Rybus-Kalinowska, A. Sliwinska, J. Stabryla, M. Kukla, J. Nowak, Z. Kalarus, M. Florescu, D. Mihalcea, L. Magda, B. Suran, O. Enescu, R. Mincu, G. Salerno, G. Scognamiglio, A. D'andrea, G. Dinardo, R. Gravino, B. Sarubbi, G. Disalvo, J.-N. Liao, S. Sung, C. Chen, S. Park, S. Shin, M. Kim, S. Shim, F. Helvacioglu, O. Ulusoy, C. Duran, R. Kirschner, T. Simor, G. Ambrosio, T. Tran, S. Raman, R. C. Vidal Perez, F. Carreras, R. Leta, S. Pujadas, A. Barros, A. Hidalgo, X. Alomar, G. Pons-Llado, M. Olofsson, K. Boman, A. Ledakowicz-Polak, L. Polak, M. Zielinska, A. Fontana, V. Schirone, A. Mauro, A. Zambon, C. Giannattasio, G. Trocino, M. Dekleva, H. Dungen, S. Inkrot, G. Gelbrich, J. Suzic Lazic, M. Kleut, N. Markovic Nikolic, F. Waagstein, S. Khoor, N. Balogh, I. Simon, K. Fugedi, I. Kovacs, M. Khoor, G. Florian, A. Kocsis, T. Szuszai, J. O'driscoll, A. Saha, R. Smith, S. Gupta, Z. Lenkey, B. Gaszner, M. Illyes, Z. Sarszegi, I. G. Horvath, B. Magyari, F. Molnar, A. Cziraki, M. F. Elnoamany, H. Badran, H. Ebraheem, A. Reda, and N. Elsheekh
- Subjects
Speckle pattern ,Acoustics ,Radiology, Nuclear Medicine and imaging ,General Medicine ,Deformation (meteorology) ,Cardiology and Cardiovascular Medicine ,Tracking (particle physics) ,Geology - Published
- 2011
- Full Text
- View/download PDF
3. COMMON ENVELOPE EJECTION FOR A LUMINOUS RED NOVA IN M101.
- Author
-
M. M. Kasliwal, Y. Cao, J. Jencson, S. R. Kulkarni, F. J. Masci, N. Blagorodnova, I. Manulis, P. M. Vreeswijk, P. Nugent, P. Wozniak, M. Fraser, C. Gonzalez-Fernandez, S. Mattila, R. Kotak, J. Polshaw, E. Kankare, K. Smith, G. Terreran, A. M. Cody, and G. B. Doran
- Subjects
BINARY stars ,CATACLYSMIC variable stars ,NOVAE (Astronomy) ,ASTRONOMICAL photometry - Abstract
We present the results of optical, near-infrared, and mid-infrared observations of M101 OT2015-1 (PSN J14021678+5426205), a luminous red transient in the Pinwheel galaxy (M101), spanning a total of 16 years. The light curve showed two distinct peaks with absolute magnitudes and , on 2014 November 11 and 2015 February 17, respectively. The spectral energy distributions during the second maximum show a cool outburst temperature of K and low expansion velocities ( km s
−1 ) for the H i, Ca ii, Ba ii, and K i lines. From archival data spanning 15–8 years before the outburst, we find a single source consistent with the optically discovered transient, which we attribute to being the progenitor; it has properties consistent with being an F-type yellow supergiant with L ∼ 8.7 L⊙ , K, and an estimated mass of M⊙ . This star has likely just finished the H-burning phase in the core, started expanding, and is now crossing the Hertzsprung gap. Based on the combination of observed properties, we argue that the progenitor is a binary system, with the more evolved system overfilling the Roche lobe. Comparison with binary evolution models suggests that the outburst was an extremely rare phenomenon, likely associated with the ejection of the common envelope of a massive star. The initial mass of the primary fills the gap between the merger candidates V838 Mon (5−10 M⊙ ) and NGC 4490-OT (30 M⊙ ). [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
4. Tumour Markers in the Differential Diagnosis of Patients With Isolated Involuntary Weight Loss.
- Author
-
Trape J, Aligue J, Vicente M, Arnau A, San-Jose A, Ordeig J, Ordeig R, Bonet M, Abril A, El-Boutrouki O, Gonzalez-Fernandez C, Sala M, Figols C, Gonzalez-Garcia E, Montsant L, and Ruiz D
- Subjects
- Antigens, Neoplasm, Carcinoembryonic Antigen, Diagnosis, Differential, Female, Humans, Keratins, Male, Sensitivity and Specificity, Weight Loss, Biomarkers, Tumor, Lung Neoplasms diagnosis
- Abstract
Background/aim: Paraneoplastic syndrome symptoms include isolated involuntary weight loss (IIWL). The differential diagnosis of cancer from other diseases may require a significant number of tests. Tumour markers (TMs) can be used for the diagnosis and stratification of patients according to cancer risk., Patients and Methods: This study included 606 patients (48% females) seen at the rapid diagnostic unit for IIWL. We determined the levels of TMs carcinoembryonic antigen, carbohydrate antigen 19-9, soluble fragments of cytokeratin 19, carbohydrate antigen 15-3, carbohydrate antigen 125, neuron specific enolase, alpha-fetoprotein, prostatic specific antigen using the multiparametric analyser COBAS 601. Two cut-off points were established, the upper reference limit described by the manufacturer and a high cut-off point suggested by Molina et al., to stratify patients according to cancer risk., Results: Patients were classified according to TM levels as follows: I) all TMs below the upper reference limit; II) highest number of TMs between the two cut-offs; III) at least one TM above the higher cut-off. The odds ratio for malignancy was 4.3 for group II and 248 for group III. These results indicate that when at least one TM is above the higher cut-off, neoplasia is highly probable., Conclusion: TM determination allowed to establish cancer risk in patients with IIWL., (Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
5. Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
- Author
-
Rodríguez-García C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, Gonzalez-Fernandez C, Mosteiro-Añon M, Calvo-Alvarez U, Perez-De-Llano L, Corbacho-Abelaira MD, Lourido-Cebreiro T, Dominguez-Juncal LM, Crespo-Diz C, Dacal-Quintas R, Pallares-Sanmartin A, Dacal-Rivas D, and Gonzalez-Barcala FJ
- Subjects
- Aged, Antibodies, Monoclonal, Humanized administration & dosage, Female, Follow-Up Studies, Glucocorticoids administration & dosage, Humans, Male, Middle Aged, Patient Acuity, Retrospective Studies, Time Factors, Treatment Outcome, Antibodies, Monoclonal, Humanized therapeutic use, Asthma drug therapy, Asthma etiology, Eosinophilia complications, Eosinophilia drug therapy
- Abstract
Background: Severe eosinophilic asthma is a high-burden disease. Mepolizumab has been effective in several randomized clinical trials. However, such success might not be applicable to patients treated in usual clinical practice. The objectives of this article are to evaluate the efficacy of mepolizumab in severe uncontrolled eosinophilic asthma under usual clinical practice, and to determine characteristics associated with the response to this treatment., Methods: We have conducted a retrospective, multicentre study, including all adult patients with severe uncontrolled eosinophilic asthma in Galicia, Spain, on whom mepolizumab treatment was started before June 2020, at least 6 months before the time of inclusion, and had received at least one dose of the drug. Patient characteristics, clinical data, respiratory function and comorbidities were collected at baseline and at the 6-month-follow-up. Responders and super-responders were defined according to clinical response and requirement of systemic corticosteroids., Results: 122 patients (mean age 58 years old) were included. In the follow-up treatment 6 months later, 75.4% of the patients were well-controlled, displaying a significant reduction in blood eosinophil counts (p < 0.001), hospital admissions and disease exacerbations (p < 0.001), and had their systemic glucocorticosteroid dose significantly reduced (p < 0.001). The inhaled corticosteroid dose was also lowered (p < 0.01) after 6 months of treatment. Around two-thirds had a clinically significant increase in FEV1, 95% of the patients were considered responders and 43% super-responders., Conclusion: In routine clinical practice, mepolizumab is effective in patients with severe eosinophilic asthma and it has a good safety profile., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
6. New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target?
- Author
-
Gonzalez-Fernandez C, González P, and Rodríguez FJ
- Abstract
Amyotrophic lateral sclerosis is a fatal neurodegenerative disorder characterized by upper and lower motor neuron degeneration, which leads to progressive paralysis of skeletal muscles and, ultimately, respiratory failure between 2-5 years after symptom onset. Unfortunately, currently accepted treatments for amyotrophic lateral sclerosis are extremely scarce and only provide modest benefit. As a consequence, a great effort is being done by the scientific community in order to achieve a better understanding of the different molecular and cellular processes that influence the progression and/or outcome of this neuropathological condition and, therefore, unravel new potential targets for therapeutic intervention. Interestingly, a growing number of experimental evidences have recently shown that, besides its well-known physiological roles in the developing and adult central nervous system, the Wnt family of proteins is involved in different neuropathological conditions, including amyotrophic lateral sclerosis. These proteins are able to modulate, at least, three different signaling pathways, usually known as canonical (β-catenin dependent) and non-canonical (β-catenin independent) signaling pathways. In the present review, we aim to provide a general overview of the current knowledge that supports the relationship between the Wnt family of proteins and its associated signaling pathways and amyotrophic lateral sclerosis pathology, as well as their possible mechanisms of action. Altogether, the currently available knowledge suggests that Wnt signaling modulation might be a promising therapeutic approach to ameliorate the histopathological and functional deficits associated to amyotrophic lateral sclerosis , and thus improve the progression and outcome of this neuropathology., Competing Interests: None
- Published
- 2020
- Full Text
- View/download PDF
7. Biochemical methane potential of microalgae biomass using different microbial inocula.
- Author
-
Gonzalez-Fernandez C, Barreiro-Vescovo S, de Godos I, Fernandez M, Zouhayr A, and Ballesteros M
- Abstract
Background: Microalgae biomass is regarded as a potential feedstock for bioenergy purposes through anaerobic digestion (AD). Even though AD is a well-proven technology, the use of new feedstocks requires in-depth studies. A lot of research has been conducted assessing methane yield without paying attention to the anaerobic microbiome and their activities. For such a goal, the present investigation was designed to link methane yield to those two later sludge characteristics. In this sense, different anaerobic sources were tested, namely adapted to microalgae biomass and adapted to sewage sludge., Results: Despite the registered differences for the anaerobic microbiome analysis and specific methane activities towards model substrates, sludge adapted to digest sewage sludge did not affect the methane yield of Chlorella sorokiniana and Scenedesmus sp. Opposite to that, sludge samples adapted to digest microalgae exhibited a concomitant increase in methane yield together with increasing digestion temperatures. More specifically, the values attained were 63.4 ± 1.5, 79.2 ± 3.1 and 108.2 ± 1.9 mL CH
4 g COD in-1 for psychrophilic, mesophilic and thermophilic digestions, respectively. While psycro- and mesophilic digestion supported similar yields (most probably linked to their anaerobic microbiome resemblance), the values attained for thermophilic digestion evidenced the usefulness of having a highly specific microbiome. The relative abundance of Firmicutes, particularly Clostridia , and Proteobacteria together with an important abundance of hydrogenotrophic methanogens was highlighted in this inoculum., Conclusion: Overall, this study showed that working with tailored anaerobic microbiome could help avoiding pretreatments devoted to methane yield enhancement.- Published
- 2018
- Full Text
- View/download PDF
8. Spatio-temporal expression pattern of frizzled receptors after contusive spinal cord injury in adult rats.
- Author
-
Gonzalez P, Fernandez-Martos CM, Gonzalez-Fernandez C, Arenas E, and Rodriguez FJ
- Subjects
- Animals, Frizzled Receptors genetics, Male, Neuroglia pathology, Neurons pathology, Rats, Rats, Wistar, Spinal Cord pathology, Spinal Cord Injuries pathology, Frizzled Receptors metabolism, Neuroglia metabolism, Neurons metabolism, Spinal Cord metabolism, Spinal Cord Injuries metabolism
- Abstract
Background: Wnt proteins are a large family of molecules that are critically involved in multiple central nervous system (CNS) developmental processes. Experimental evidences suggest a role for this family of proteins in many CNS disorders, including spinal cord injury (SCI), which is a major neuropathology owing to its high prevalence and chronic sensorimotor functional sequelae. Interestingly, most Wnt proteins and their inhibitors are expressed in the uninjured spinal cord, and their temporal expression patterns are dramatically altered after injury. However, little is known regarding the expression of their better-known receptors, the Frizzled family, after SCI. Thus, the aim of the present study was to evaluate the expression of Frizzled receptors in the damaged spinal cord., Findings: Based on the evidence that Wnts are expressed in the spinal cord and are transcriptionally regulated by SCI in adulthood, we analysed the spatio-temporal mRNA and protein expression patterns of Frizzled receptors after contusive SCI using quantitative RT-PCR and single and double immunohistochemistry, respectively. Our results show that almost all of the 10 known Frizzled receptors were expressed in specific spatial patterns in the uninjured spinal cords. Moreover, the Frizzled mRNAs and proteins were expressed after SCI, although their expression patterns were altered during the temporal progression of SCI. Finally, analysis of cellular Frizzled 5 expression pattern by double immunohistochemistry showed that, in the uninjured spinal cord, this receptor was expressed in neurons, oligodendrocytes, astrocytes, microglia and NG2(+) glial precursors. After injury, Frizzled 5 was not only still expressed in oligodendrocytes, astrocytes and NG2(+) glial precursors but also in axons at all evaluated time points. Moreover, Frizzled 5 was expressed in reactive microglia/macrophages from 3 to 14 days post-injury., Conclusions: Our data suggest the involvement of Frizzled receptors in physiological spinal cord function and in the cellular and molecular events that characterise its neuropathology.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.